Fri, Jul 12, 2013 -- 9:00 AM

Genetic Mutation Holds Promise for Cholesterol-Busting Drug

Download audio (MP3)

Getty Images
Getty Images

After two women with similar genetic mutations were found to have astoundingly low cholesterol, drug companies began racing to release a super-drug that mimics that cholesterol-destroying mutation. New York Times science writer Gina Kolata and the director of the National Heart, Lung, and Blood Institute, Dr. Gary Gibbons, discuss these findings, and whether a super-drug could make high cholesterol a thing of the past.

Host: Dave Iverson


  • Dr. Gary Gibbons, director of the National Heart, Lung, and Blood Institute at the National Institutes of Health
  • Gina Kolata, science reporter for the New York Times

Become a KQED sponsor

Audio Archive

Episodes by Date

Calendar is loading...

Be a Part of Forum

Follow us on Twitter

Twitter bird in blue

Stay updated on show topics, relevant articles, and easily submit your questions.

Subscribe to Forum


Subscribe to Forum's podcast and you'll automatically get each new episode when it becomes available. You'll never miss out!